Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 751 Jan 1 – Oct 25, 2026
- Disclosed funding
- $25.9B 611 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| CT Connecta TherapeuticsCompany profile Connecta Therapeutics develops small-molecule treatments for neurological disorders, including CTH120, a clinical-stage candidate for Fragile X syndrome. Connecta Therapeutics develops small-molecule treatments for neurological disorders, including CTH120, a clinical-stage candidate for Fragile X syndrome. | €3.1M | Clinical development financingUndisclosed | Healthtech, Biotech | Spain | Investors | |
| MF MIRROR FIT., Inc.Company profile A fitness company combining connected workout mirrors with private women-only gyms. A fitness company combining connected workout mirrors with private women-only gyms. | ¥250M | FundingUndisclosed | Healthtech | Japan | Investors | |
| F FullscriptCompany profile Fullscript helps healthcare practitioners build and deliver personalized supplement, lab and follow-up plans for patients. Fullscript helps healthcare practitioners build and deliver personalized supplement, lab and follow-up plans for patients. | Undisclosed | Majority investmentUndisclosed | Healthtech | Canada | Investors | |
| MI Medteria, Inc.Company profile A professional communication platform connecting healthcare workers and medical students with their communities and employers. A professional communication platform connecting healthcare workers and medical students with their communities and employers. | ¥140M | FundingUndisclosed | Healthtech | Japan | Investors | |
| DI DermaSensor Inc.Company profile A handheld skin-lesion assessment device helps primary-care clinicians evaluate suspicious lesions for cancer risk. A handheld skin-lesion assessment device helps primary-care clinicians evaluate suspicious lesions for cancer risk. | $4M | Series B extensionSeries B | Healthtech | United States | Investors Undisclosed | |
| S SystemCompany profile An online care platform connects patients with licensed clinicians for personalized health assessments and prescribed treatments. An online care platform connects patients with licensed clinicians for personalized health assessments and prescribed treatments. | $20M | FundingUndisclosed | Healthtech | United States | Investors | |
| I ImplicityCompany profile Implicity provides AI-powered remote cardiac monitoring and data-management software that helps care teams interpret information from implanted heart devices. Implicity provides AI-powered remote cardiac monitoring and data-management software that helps care teams interpret information from implanted heart devices. | €35M | Growth equityGrowth | Healthtech | France | Investors | |
| AL Anemo LabsCompany profile Anemo Labs is developing an electronic nose that combines proprietary sensors with AI to detect disease-related signals in bodily fluids for non-invasive health screening. Anemo Labs is developing an electronic nose that combines proprietary sensors with AI to detect disease-related signals in bodily fluids for non-invasive health screening. | £700K | Pre-seed | Healthtech | United Kingdom | Investors | |
| VH Verily HealthCompany profile An AI-native precision-health platform organizes complex health data for research, care and personalized health services. An AI-native precision-health platform organizes complex health data for research, care and personalized health services. | Undisclosed | March financing extensionUndisclosed | Healthtech | United States | Investors | |
| NM Neurent MedicalCompany profile Neurent Medical develops NEUROMARK, a minimally invasive radiofrequency treatment for chronic rhinitis. Neurent Medical develops NEUROMARK, a minimally invasive radiofrequency treatment for chronic rhinitis. | $25M | Growth investmentGrowth | Healthtech | Ireland | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.